Fiorenzo Conti Selected Research

familial type 2 Hemiplegic migraine

1/2021	Non-canonical glutamate signaling in a genetic model of migraine with aura.
1/2016	Defective glutamate and K+ clearance by cortical astrocytes in familial hemiplegic migraine type 2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fiorenzo Conti Research Topics

Disease

11	Alzheimer Disease (Alzheimer's Disease) 11/2021 - 04/2014
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2019
3	Cognitive Dysfunction 10/2020 - 01/2016
3	Epilepsy (Aura) 01/2020 - 07/2004
3	Schizophrenia (Dementia Praecox) 05/2010 - 05/2005
2	Migraine Disorders (Migraine) 01/2021 - 01/2016
2	Migraine with Aura (Familial Hemiplegic Migraine) 01/2021 - 01/2016
2	familial type 2 Hemiplegic migraine 01/2021 - 01/2016
2	Dementia (Dementias) 10/2020 - 08/2018
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 09/2017 - 04/2014
2	Disease Progression 09/2017 - 04/2014
2	Ischemia 07/2004 - 10/2003
1	Nervous System Diseases (Neurological Disorders) 01/2021
1	Neurobehavioral Manifestations 10/2020
1	Parkinson Disease (Parkinson's Disease) 02/2020
1	Mental Disorders (Mental Disorder) 01/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2015
1	Seizures (Absence Seizure) 01/2006
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2003

Drug/Important Bio-Agent (IBA)

5	Glutamic Acid (Glutamate)FDA Link 01/2021 - 01/2006
5	gamma-Aminobutyric Acid (GABA)IBA 01/2020 - 10/2003
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2020 - 01/2017
3	Mitochondrial DNA (mtDNA)IBA 02/2020 - 04/2014
2	Amyloid beta-PeptidesIBA 11/2021 - 11/2018
2	Biomarkers (Surrogate Marker)IBA 10/2020 - 08/2018
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2017
2	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2016 - 05/2010
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 04/2014 - 05/2010
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 11/2021
1	Cholinergic Agents (Cholinergics)IBA 11/2021
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021
1	nilotinib FDA Link 01/2021
1	NucleotidesIBA 02/2020
1	Aminobutyrates (Aminobutyric Acid)IBA 01/2020
1	GABA Plasma Membrane Transport ProteinsIBA 01/2020
1	Amyloid (Amyloid Fibrils)IBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Metabotropic Glutamate 5 ReceptorIBA 09/2017
1	metabotropic glutamate receptor type 1IBA 09/2017
1	Nerve Growth Factors (Neurotrophins)IBA 01/2017
1	Protein Isoforms (Isoforms)IBA 01/2016
1	Adenosine Triphosphatases (ATPase)IBA 01/2016
1	Phospholipases A2 (Phospholipase A2)IBA 01/2016
1	Amino Acid Transport System X-AG (Glutamate Transporter)IBA 05/2009
1	Antipsychotic Agents (Antipsychotics)IBA 05/2005
1	HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA 10/2003

Therapy/Procedure

1	Cognitive Training 07/2020
1	Therapeutics 01/2019